Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3840973 | Translational Research | 2009 | 9 Pages |
Abstract
Systemic lupus erythematosus (SLE) is associated with an increase in the risk of premature cardiovascular complications caused by accelerated atherosclerosis, which significantly contributes to morbidity and mortality. Standard Framingham risk factors seem to be less important predictors of cardiovascular events than the presence of active SLE, and the immune dysregulation characteristic of lupus seems to play a dominant role in atherogenesis. Although both SLE-specific and nonspecific mechanisms have been proposed to play a prominent role in the induction of premature vascular damage in this disease, the exact etiology remains unclear. This review summarizes some of the proposed mechanisms that may promote accelerated vascular damage in lupus and explores potential targets for cardiovascular risk prevention in this patient population.
Keywords
MMFCACSOx-LDLautoAbTZDVLDLLPLEPCsDCsIFN-αAPLHDLAPshigh-density lipoproteinOxidized LDLAutoantibodyInterferon-αcardiovascular diseaseCVDEndothelial cellDendritic cellsEndothelial progenitor cellsAntiphospholipid syndromeantiphospholipidcardiovascularSystemic lupus erythematosusSLELipoprotein lipasevery low-density lipoproteinLow-density lipoproteinLDLmycophenolate mofetilimmune complexNitric oxidecirculating angiogenic cells
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Mariana J. Kaplan,